Uncategorized

AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits

AlloSource a Samaritan Institute finalist in the 2010 Colorado Ethics in Business Alliance Awards

CENTENNIAL, Colo., Dec. 17 /PRNewswire/ — AlloSource, one of the nation’s largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world’s largest processor of live cellular bone growth substitutes, today announced that is has been selected as a finalist in the 2010 Colorado Ethics in Business Alliance (CEBA) Awards, in the Samaritan Institute category honoring non-profits. This is the second year in a row that AlloSource has been selected as a finalist by the annual awards program, now in its 18th year.

CEBA’s Samaritan Institute Award recognizes non-profits that demonstrate a high level of effectiveness in carrying out their stated missions. Additionally, the award seeks organizations that adhere firmly to ethical standards of conduct, treatment of staff and treatment of clients, are highly successful at raising funds and run effective business operations that include cooperation and coordination with other entities and individuals.

Since 1994, AlloSource has been run on a promise: to honor and respect the gift of tissue donation by responsibly developing, processing and distributing life-saving and life-enhancing allografts for its communities. The Company delivers on this promise with safe, effective and innovative allografts.

“It is with great pride that we are again named a CEBA finalist, because living our mission is at the core of what we do,” said Thomas Cycyota, AlloSource President and CEO. “We strive to be a trusted, valued, knowledgeable partner to the medical community as well as to patients and donor families, and our associates are instrumental in making that happen every day.”

In 2008, AlloSource saved and enhanced the lives of more people in more communities than ever before. The Company processed more than 4,150 tissue donors whose gifts helped thousands of people to improve their mobility and functionality. This allowed AlloSource to provide 144,899 allografts, 10% more than the previous year, to patients in its local communities, including in Colorado. Additionally, AlloSource processed more than 3,200 skin donors whose generous gifts helped save the lives of burn victims around the country.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button